This week we are going to discuss a relatively rare but painful condition called cervical dystonia or spasmodic torticollis. Cervical dystonia is a condition of adulthood that generally occurs after ...

After debuting in the aesthetics market with Daxxify last year, Revance has made its way to the potentially lucrative therapeutic space. With a Monday FDA nod to treat cervical dystonia in adults, ...

About Cervical Dystonia According to the Dystonia Medical Research Foundation, cervical dystonia is a painful condition in which the neck muscles contract involuntarily, causing abnormal movements and ...

The US Food and Drug Administration (FDA) has expanded the indiction for daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) for the treatment of cervical dystonia in adults, the ...

DaxibotulinumtoxinA for Injection for treatment for cervical dystonia met the primary and all secondary endpoints in the phase 3 ASPEN-1 study, according to topline results released today by Revance ...

This week we are going to discuss a rather obscure topic…that of intra-articular inclusions in cervical facet joints. The cervical facet joints include the very top alanto-occipital joint, the second ...

Dear Dr. Gott: I have been diagnosed with torticollis. I am 60 years old but was diagnosed with the condition about 25 years ago. The doctor said it was a mild case and didn't feel it would get any ...

The U.S. FDA has approved Daxxify (daxibotulinumtoxinA-lanm) for treating cervical dystonia in adults nearly a week ahead of its Aug. 19 PDUFA date. Approval of the sBLA for the injectable, ...

DEAR DR. ROACH: I have a friend in his early 50s who has always been healthy. He has just been diagnosed with cervical dystonia. His head bobbles. He has had Botox shots, but these did not help. It ...

(RTTNews) - Revance Therapeutics Inc. (RVNC) said Thursday that it will present results from its ASPEN-1 Phase 3 clinical trial evaluating the efficacy, duration of effect and safety of ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC) a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that it has submitted a ...